Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,203,342
+$164,828 QoQ
Shares Held
4,782
+0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#2,375
of 4,153 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Darden Wealth Group Inc holds $5,302,155 across 5 Drug Manufacturers - General names. ABBV ranks #2 (22.7% of the industry book) .
All Filings in ABBV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,203,342 | 4,782 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,038,514 | 4,775 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,091,039 | 4,775 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,071,335 | 4,627 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $858,863 | 4,627 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $1,012,400 | 4,832 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $858,646 | 4,832 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $934,475 | 4,732 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $785,047 | 4,577 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $757,353 | 4,159 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $308,545 | 1,991 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||